Atara Biotherapeutics, Inc.

ATRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A May 15, 2025
424B5 May 15, 2025 424B5
10-Q May 15, 2025 10-Q
8-K May 15, 2025 8-K
8-K May 12, 2025 8-K
8-K May 6, 2025 8-K
DEFA14A Apr 28, 2025 DEFA14A
DEF 14A Apr 28, 2025 DEF 14A
3 Apr 10, 2025
8-K Apr 4, 2025 8-K
4 Apr 2, 2025
8-K Mar 31, 2025 8-K
10-K Mar 7, 2025 10-K
8-K Mar 7, 2025 8-K
4 Mar 5, 2025
4 Mar 5, 2025
4 Mar 5, 2025
144 Mar 3, 2025
144 Mar 3, 2025
144 Mar 3, 2025
8-K Mar 3, 2025 8-K
SCHEDULE 13G Feb 6, 2025
4 Jan 29, 2025
8-K Jan 27, 2025 8-K
8-K Jan 21, 2025 8-K
← Newer Page 5 of 46 · 1130 filings Older →